Patents by Inventor Christina Liquori

Christina Liquori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7442782
    Abstract: The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: October 28, 2008
    Assignee: Regents of the University of Minnesota
    Inventors: Laura P. W. Ranum, John W. Day, Christina Liquori
  • Patent number: 6902896
    Abstract: The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or are at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: June 7, 2005
    Assignee: Regents of the University of Minnesota
    Inventors: Laura P. W. Ranum, John W. Day, Christina Liquori
  • Publication number: 20050003426
    Abstract: The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
    Type: Application
    Filed: July 14, 2004
    Publication date: January 6, 2005
    Applicant: Regents of the University of Minnesota
    Inventors: Laura Ranum, John Day, Christina Liquori
  • Publication number: 20030108887
    Abstract: The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
    Type: Application
    Filed: May 10, 2002
    Publication date: June 12, 2003
    Inventors: Laura P.W. Ranum, John W. Day, Christina Liquori